BridgeBio Pharma (BBIO) Q3 2026 Earnings

30JulConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-0.95
-0.83
-0.71
-0.59

Details

Expected EPS
-0.588675
Actual EPS
N/A
Surprise EPS
0.59
Surprise Percent
+100%

Description

BridgeBio Pharma (BBIO) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts